GS
ZBH icon

GTS Securities’s Zimmer Biomet ZBH Stock Holding History

GTS Securities’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-7,100
Closed -$766K – 4265
2024
Q3 		$766K Buy
7,100
+2,600
+58% +$284K ﹤0.01% 2407
2024
Q2 		$488K Buy
+4,500
New +$530K ﹤0.01% 2722
2023
Q4 		– Sell
-7,700
Closed -$864K – 4470
2023
Q3 		$864K Buy
+7,700
New +$978K ﹤0.01% 2127

Other funds holding ZBH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

GTS Securities's ZBH Position: Q1 2025 in Review

GTS Securities sold out of Zimmer Biomet (ZBH) in Q1 2025, closing a stake of 2,655 shares — an estimated $280K sold.

GTS Securities first reported a position in ZBH in Q2 2023 and held it in 7 quarters. The position peaked at $1.13M in Q2 2023. 1,000 funds tracked by Wall St. Rank hold ZBH as of Q1 2025.

  • GTS Securities reported no remaining Zimmer Biomet position as of Q1 2025 after selling out during the quarter.
  • GTS Securities sold 2,655 Zimmer Biomet shares in Q1 2025, an estimated $280K.
  • GTS Securities first reported a position in Zimmer Biomet in Q2 2023 and held it in 7 quarters.
  • GTS Securities's Zimmer Biomet position peaked at $1.13M in Q2 2023.
  • 1,000 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2025.

Based on GTS Securities's 13F filing for Q1 2025, filed 15 May 2025.